Skip to main content


Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients

By The Hill  
   October 30, 2020

Regeneron Pharmaceuticals said Friday it has paused a clinical study of its antibody drug to treat some of the sickest COVID-19 patients because of a potential safety concern.

Full story

Get the latest on healthcare leadership in your inbox.